Endothelial derived, secreted long non-coding RNAs
MT:Non-coding RNAs
calcium/calmodulin-dependent protein kinase type II
cardiac angiogenesis
extracellular vesicles
heart failure
hypertrophy
Journal
Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621
Informations de publication
Date de publication:
10 Sep 2024
10 Sep 2024
Historique:
received:
30
01
2024
accepted:
12
08
2024
medline:
17
9
2024
pubmed:
17
9
2024
entrez:
16
9
2024
Statut:
epublish
Résumé
Pathological cardiac remodeling predisposes individuals to developing heart failure. Here, we investigated two co-regulated long non-coding RNAs (lncRNAs), termed
Identifiants
pubmed: 39281699
doi: 10.1016/j.omtn.2024.102306
pii: S2162-2531(24)00193-8
pmc: PMC11402397
doi:
Types de publication
Journal Article
Langues
eng
Pagination
102306Informations de copyright
© 2024 The Author(s).
Déclaration de conflit d'intérêts
The patent for the use of lncRNA Gadlor1 and Gadlor2 in treating and preventing cardiac remodeling has been granted to N. Froese, J.B., and J.H. (US11208656, granted on 28.01.2021).